BTAI icon

BioXcel Therapeutics

73 hedge funds and large institutions have $26.1M invested in BioXcel Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

35% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 26

44% less call options, than puts

Call options by funds: $422K | Put options by funds: $754K

Holders
73
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$422K
Puts
$754K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.03M
2
$3.75M
3
$3.1M
4
$1.63M
5
$1.31M
6
$1.29M
7
$1.05M
8
$851K
9
$627K
10
$597K
11
$539K
12
$415K
13
$347K
14
$347K
15
$274K
16
$254K
17
$237K
18
$136K
19
$135K
20
$134K
21
$127K
22
$120K
23
$115K
24
$113K
25
$107K